BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 32432571)

  • 1. Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis.
    Zhang X; Zhang Y; Li R; Zhu L; Fu B; Yan T
    Aging (Albany NY); 2020 May; 12(10):9405-9426. PubMed ID: 32432571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
    Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
    Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salsolinol Induces Parkinson's Disease Through Activating NLRP3-Dependent Pyroptosis and the Neuroprotective Effect of Acteoside.
    Wang Y; Wu S; Li Q; Lang W; Li W; Jiang X; Wan Z; Sun H; Wang H
    Neurotox Res; 2022 Dec; 40(6):1948-1962. PubMed ID: 36454451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
    Zhang M; He Q; Chen G; Li PA
    Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis.
    Li Y; Song W; Tong Y; Zhang X; Zhao J; Gao X; Yong J; Wang H
    J Neuroinflammation; 2021 Jan; 18(1):1. PubMed ID: 33402173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
    Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Hydroxybutyrate alleviates pyroptosis in MPP
    Jiang Z; Yin X; Wang M; Wang Y; Li F; Gao Y; Han G; Gao Z; Wang Z
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109451. PubMed ID: 36423429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis.
    Xing SS; Yang J; Li WJ; Li J; Chen L; Yang YT; Lei X; Li J; Wang K; Liu X
    Inflammation; 2020 Apr; 43(2):433-440. PubMed ID: 32076940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium para-aminosalicylic acid inhibits manganese-induced NLRP3 inflammasome-dependent pyroptosis by inhibiting NF-κB pathway activation and oxidative stress.
    Peng D; Li J; Deng Y; Zhu X; Zhao L; Zhang Y; Li Z; Ou S; Li S; Jiang Y
    J Neuroinflammation; 2020 Nov; 17(1):343. PubMed ID: 33203418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis.
    Cai Y; Chai Y; Fu Y; Wang Y; Zhang Y; Zhang X; Zhu L; Miao M; Yan T
    Front Aging Neurosci; 2021; 13():809433. PubMed ID: 35126093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
    Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
    Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.
    Bian Y; Li X; Pang P; Hu XL; Yu ST; Liu YN; Li X; Wang N; Wang JH; Xiao W; Du WJ; Yang BF
    Acta Pharmacol Sin; 2020 Mar; 41(3):319-326. PubMed ID: 31645662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation.
    He Z; Hu Y; Zhang Y; Xie J; Niu Z; Yang G; Zhang J; Zhao Z; Wei S; Wu H; Hu W
    Phytomedicine; 2024 May; 127():155494. PubMed ID: 38471370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qiji Shujiang granules alleviates dopaminergic neuronal injury of parkinson's disease by inhibiting NLRP3/Caspase-1 pathway mediated pyroptosis.
    Huan P; Sun X; He Z; Yang S; Wang X; Xie H; Wang L; He J
    Phytomedicine; 2023 Nov; 120():155019. PubMed ID: 37657208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
    Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
    Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
    Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
    J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.